Analyst Consensus ?
ConsensusBuy45 ratings
Bullish3066.7%
Neutral1533.3%
Bearish00.0%
EQT Corporation · EQT · FY2024 Q3 · Calendar Q4 2024
EQT highlights integration synergies and raised Q4 production guidance
EQT's Q3 2024 analysis supports a constructive operating thesis: rapid Equitrans integration, reported synergies, and a low-cost vertically integrated model may strengthen execution and demand positioning. The thesis still depends on commodity prices, asset-sale progress, curtailment flexibility, and delivery of planned compression and integration benefits.
Reported After market closeNYSEEnergy
$34.80B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$0.12
Consensus $0.05
EPS surprise
+140.0%
Reported versus consensus
Reported revenue
$1.22B
Consensus $1.80B
Revenue surprise
-32.5%
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
+3.4%
Event window
SPY move
-0.3%
Same window
Abnormal move
+3.7%
Stock minus SPY
Volume
1.6×
Versus trailing sessions
Subsequent drift
+17.4%
Up to 20 sessions
EQTSPY benchmark
Ask FN2 about EQT FY2024 Q3
Transcript, numbers and history already loaded
Why did EQT rise 3.4% after beating EPS estimates in FY2024 Q3?What changed in EQT's guidance and outlook in FY2024 Q3?Give me the bull and bear case for EQT after FY2024 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, management's analysis shifted from maintained to raised guidance, while highlighting $145 million of annualized synergies, net-zero Scope 1 and 2 emissions ahead of target, and a $1.25 billion non-operating asset sale with debt retirements. The supplied analysis also points to modestly higher capex and continued integration work.
Guidance delta
Management raised Q4 production guidance and indicated modestly higher capital expenditure.
Key takeaways
- Management's analysis says Equitrans integration produced $145 million of annualized synergies within three months, ahead of schedule.
- The vertically integrated model is presented as supporting low-cost production and flexibility to curtail volumes when prices are volatile.
- EQT said it achieved net-zero Scope 1 and 2 emissions ahead of its 2025 target, according to the supplied analysis.
- Management linked medium-term natural-gas demand to coal retirements, data-center power needs, and AI-related generation.
Management priorities
- Incorporate remaining integration progress into the 2025 budget and capture additional synergies.
- Scale compression projects and continue water-system connectivity investments.
- Continue asset sales to support the 2025 debt-reduction target.
- Maintain net-zero Scope 1 and 2 status and expand the carbon-offset partnership.
Follow EQT with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$54.73Current
$22Low
$44.5Average
$73High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 26, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Buy | Buy | Maintain | Oct 15, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Oct 15, 2026 |
| Jefferies | Buy | Buy | Maintain | Sep 29, 2026 |
| Citigroup | Buy | Buy | Maintain | Sep 23, 2026 |
| Stephens & Co. | Overweight | Overweight | Maintain | Sep 17, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Aug 19, 2026 |
| Barclays | Overweight | Overweight | Maintain | Aug 17, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jun 24, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Apr 23, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Apr 15, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Apr 6, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Mar 27, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Mar 17, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Mar 5, 2026 |
| TD Cowen | Buy | Buy | Maintain | Feb 20, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jan 5, 2026 |
| Scotiabank | Sector Perform | Sector Perform | Maintain | Nov 21, 2025 |
| B of A Securities | Buy | Buy | Maintain | Aug 22, 2025 |
| Roth Capital | Neutral | Buy | Downgrade | Aug 18, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Feb 12, 2025 |
| Tudor Pickering | Buy | Hold | Upgrade | Jun 20, 2023 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Dec 14, 2022 |
| Credit Suisse | Outperform | Outperform | Maintain | Jul 28, 2022 |
| MKM Partners | Buy | Buy | Maintain | Oct 23, 2020 |
| TD Securities | Buy | Buy | Maintain | Jul 28, 2020 |
| CFRA | Hold | Hold | Maintain | May 8, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Apr 24, 2020 |
| Stifel | Hold | Hold | Maintain | Apr 20, 2020 |
| Stifel Nicolaus | Buy | Buy | Maintain | Jan 27, 2020 |
| Macquarie | Neutral | Neutral | Maintain | May 30, 2019 |
| Cowen & Co. | Perform | Market Perform | Maintain | Apr 9, 2019 |
| Drexel Hamilton | Buy | Buy | Maintain | Nov 17, 2016 |
| Scotia Howard Weil | Sector Perform | Outperform | Downgrade | Aug 11, 2016 |
| Deutsche Bank | Hold | Buy | Downgrade | Jun 14, 2016 |
| GMP Securities | Buy | Buy | Maintain | Feb 3, 2016 |
| Seaport Global | Accumulate | Buy | Maintain | Jan 13, 2016 |
| KLR Group | Hold | Buy | Downgrade | Apr 20, 2015 |
| ISI Group | Buy | Buy | Maintain | Sep 10, 2014 |
| Oppenheimer | Outperform | Outperform | Maintain | Apr 15, 2014 |
| Maxim Group | Buy | Buy | Maintain | Nov 13, 2013 |
| Societe Generale | Hold | Buy | Downgrade | May 22, 2013 |
| Canaccord Genuity | Hold | Hold | Maintain | Dec 20, 2012 |
| Brean Capital | Hold | Buy | Downgrade | May 2, 2012 |
| Pritchard Capital Partners | Buy | Neutral | Upgrade | Apr 30, 2012 |
| Ladenburg Thalmann | Hold | Buy | Downgrade | Dec 8, 2011 |
Named analyst price targets
Upside is calculated against the persisted current price $54.73. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Scotiabank | Analyst unavailable | $54 | $52.75 | -1.3% | Oct 14, 2026 |
| Stifel Nicolaus | David Deckelbaum | $66 | $54.62 | +20.6% | Sep 9, 2026 |
| Stephens | Mike Scialla | $72 | $52.73 | +31.6% | Jul 22, 2026 |
| Stephens | Mike Scialla | $71 | $49.81 | +29.7% | Jul 15, 2026 |
| UBS | Josh Silverstein | $73 | $51.22 | +33.4% | Jul 8, 2026 |
| RBC Capital | Scott Hanold | $49 | $44.53 | -10.5% | Dec 3, 2024 |
| Stephens | Mike Scialla | $38 | $37.31 | -30.6% | Oct 30, 2024 |
| Mizuho Securities | Nitin Kumar | $41 | $36.94 | -25.1% | Oct 4, 2024 |
| Citigroup | Scott Gruber | $44 | $37.26 | -19.6% | Oct 3, 2024 |
| Mizuho Securities | Nitin Kumar | $43 | $33.19 | -21.4% | Sep 16, 2024 |
| Citigroup | Paul Diamond | $37 | $32.9 | -32.4% | Aug 22, 2024 |
| Piper Sandler | Mark Lear | $32 | $31.48 | -41.5% | Aug 15, 2024 |
| Wells Fargo | Roger Read | $42 | $31.15 | -23.3% | Aug 13, 2024 |
| Piper Sandler | Mark Lear | $43 | $34.38 | -21.4% | Jul 25, 2024 |
| Piper Sandler | Mark Lear | $47 | $35.6 | -14.1% | Jul 18, 2024 |
| Scotiabank | Cameron Bean | $55 | $37.11 | +0.5% | Jul 12, 2024 |
| Jefferies | Lloyd Byrne | $49 | $36.98 | -10.5% | Jun 30, 2024 |
| Jefferies | Lloyd Byrne | $48 | $40.98 | -12.3% | Jun 3, 2024 |
| Evercore ISI | Stephen Richardson | $50 | $39.91 | -8.6% | May 24, 2024 |
| BMO Capital | Phillip Jungwirth | $47 | $39.35 | -14.1% | May 13, 2024 |
| Piper Sandler | Mark Lear | $46 | $41.05 | -16.0% | Apr 30, 2024 |
| Wolfe Research | Josh Silverstein | $46 | $39.43 | -16.0% | Apr 24, 2024 |
| Piper Sandler | Mark Lear | $41 | $36.22 | -25.1% | Apr 19, 2024 |
| Wells Fargo | Roger Read | $37 | $36.2 | -32.4% | Apr 17, 2024 |
| Mizuho Securities | Nitin Kumar | $40 | $36.52 | -26.9% | Apr 16, 2024 |
| Scotiabank | Cameron Bean | $52 | $37.71 | -5.0% | Apr 11, 2024 |
| Bernstein | Jean Ann Salisbury | $34 | $37.95 | -37.9% | Apr 10, 2024 |
| Jefferies | Lloyd Byrne | $43 | $36.76 | -21.4% | Apr 5, 2024 |
| Stephens | Mike Scialla | $36 | $39.66 | -34.2% | Jul 13, 2023 |
| Truist Financial | Neal Dingmann | $28 | $32.65 | -48.8% | Apr 11, 2023 |
| Goldman Sachs | Analyst unavailable | $49 | $33.87 | -10.5% | Dec 29, 2022 |
| Citigroup | Analyst unavailable | $40 | $36.91 | -26.9% | Dec 7, 2022 |
| Piper Sandler | Analyst unavailable | $63 | $41.49 | +15.1% | Nov 17, 2022 |
| Citigroup | Analyst unavailable | $60 | $46.56 | +9.6% | Sep 21, 2022 |
| BMO Capital | Phillip Jungwirth | $65 | $46.56 | +18.8% | Sep 20, 2022 |
| RBC Capital | Analyst unavailable | $57 | $47.89 | +4.1% | Sep 9, 2022 |
| Goldman Sachs | Analyst unavailable | $53 | $47.7 | -3.2% | Aug 22, 2022 |
| Mizuho Securities | Analyst unavailable | $59 | $47.72 | +7.8% | Aug 18, 2022 |
| Piper Sandler | Mark Lear | $59 | $42.31 | +7.8% | Aug 2, 2022 |
| Credit Suisse | Analyst unavailable | $52 | $45.44 | -5.0% | Jul 28, 2022 |
| Morgan Stanley | Analyst unavailable | $48 | $38.48 | -12.3% | Jul 19, 2022 |
| Mizuho Securities | Analyst unavailable | $55 | $38.7 | +0.5% | Jul 19, 2022 |
| Wells Fargo | Analyst unavailable | $62 | $34.2 | +13.3% | Jul 11, 2022 |
| Credit Suisse | Analyst unavailable | $50 | $46.71 | -8.6% | Jun 13, 2022 |
| Morgan Stanley | Analyst unavailable | $50 | $47.99 | -8.6% | Jun 6, 2022 |
| Mizuho Securities | Analyst unavailable | $65 | $48.32 | +18.8% | May 31, 2022 |
| Wells Fargo | Analyst unavailable | $51 | $39.45 | -6.8% | May 3, 2022 |
| Credit Suisse | Analyst unavailable | $41 | $40.97 | -25.1% | Apr 28, 2022 |
| Morgan Stanley | Analyst unavailable | $47 | $42.32 | -14.1% | Apr 22, 2022 |
| Cowen & Co. | David Deckelbaum | $23 | $19.74 | -58.0% | Oct 13, 2021 |
| Piper Sandler | Kashy Harrison | $27 | $20.76 | -50.7% | Oct 8, 2021 |
| Citigroup | Kevin Cunane | $23 | $18 | -58.0% | Aug 30, 2021 |
| Tudor Pickering | Sameer Panjwani | $27 | $18.28 | -50.7% | Jul 30, 2021 |
| Credit Suisse | William Janela | $26 | $18.58 | -52.5% | Jul 29, 2021 |
| TD Securities | Aaron Bilkoski | $27 | $21.04 | -50.7% | Jun 29, 2021 |
| Goldman Sachs | Neil Mehta | $22 | $17.28 | -59.8% | Apr 20, 2021 |
Track every rating change on EQT the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationEQT Corporation primarily functions as an extractor of natural gas within the United States. In addition to natural gas, the firm also obtains various natural gas liquids (NGLs), specifically ethane, propane, isobutane, butane, and natural gasoline. By the end of 2021, EQT possessed certified reserves amounting to 25.0 trillion cubic feet of natural gas, NGLs, and crude oil. These reserves are situated across roughly 2.0 million gross acres, with a significant 1.7 million gross acres located within the Marcellus shale formation. The company, which dates back to its founding in 1878, has its principal offices in Pittsburgh, Pennsylvania.
Historical context
All EQT earningsEnergy peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| SLB Slb N.V. | FY2026 Q3 · Calendar Q4 2026 | +3.7% | +7.1% | SLB Q3 2026: Growth Broadens Beyond Core Oilfield |
| E Eni S.p.A. | FY2026 Q3 · Calendar Q4 2026 | +13.9% | +4.3% | Eni pairs upstream growth with record shareholder returns and transition progress |
| VLO Valero Energy Corporation | FY2026 Q3 · Calendar Q4 2026 | +12.9% | -2.4% | Valero Q3: Record Profitability, Strong Cash Generation and Execution Risks |
Latest beats and misses
Who reports nextBeat on EPS
- FCNCAFY2026 Q3 · October 23, 2026+19.9% EPS+8.2% move
- FCNCNFY2026 Q3 · October 23, 2026+19.9% EPS+0.2% move
- FCNCOFY2026 Q3 · October 23, 2026+19.9% EPS+1.0% move
- FCNCPFY2026 Q3 · October 23, 2026+19.9% EPS+1.0% move
- RDYFY2027 Q2 · October 23, 2026+24.0% EPS-0.2% move
- SLBFY2026 Q3 · October 23, 2026+3.7% EPS+7.1% move
Missed on EPS
- INFYFY2027 Q2 · October 23, 2026-4.8% EPS-6.6% move
- BBDFY2026 Q3 · October 22, 2026-7.7% EPS+3.0% move
- SNAFY2026 Q3 · October 22, 2026-5.9% EPS-3.4% move
- SPOTFY2026 Q3 · October 22, 2026-11.6% EPS+11.1% move
- VRSNFY2026 Q3 · October 22, 2026-2.0% EPS-0.9% move
- HBANMFY2026 Q3 · October 22, 2026-5.3% EPS+0.5% move
Get the EQT recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-11-10T18:38:36.707185+00:00
- Polygon adjusted daily market bars · 2026-10-26T16:50:42.808223+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-26T16:50:42.805488+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-26. For educational purposes only; not investment advice.